Anda di halaman 1dari 2

Strength in unity

FORTUNE 500 CORPORATION | BIOPHARMACEUTICALS | UNITED STATES

A biopharma leader partners with ZS—and makes its


forecasting more consistent, transparent and efficient.
BUSINESS ISSUE THE PROBLEM
Reshaping forecasts from a global perspective Many affiliates, and many different forecasts
Pharmaceutical companies depend on forecasting to inform A global biopharmaceutical company was expanding its footprint
them on issues ranging from evaluating prospective partnerships and preparing to launch multiple new indications and products.
to spotting gaps in the portfolio to determining capital and But the company was not entirely confident in its ability to roll up
resource investments. Without a robust forecasting function, forecasts at a global level, given the size and resources required.
navigating the pharmaceutical market is difficult at best.
“If you could have looked at my hard drive, you’d see the many
Depending upon their situation and philosophy, many folders and number of files and the lack of continuity that
pharmaceutical companies rely on individual affiliates to existed,” according to an associate director. “There was never
generate local forecasts. While affiliates provide valuable a way for the different processes to come together.”
insights about local markets, their individual approaches are
often inconsistent with one another. The company needed a global process for nearly 40 local
affiliates. Disparities in methodologies threatened to frustrate
Leveraging affiliates for local forecasts can be successful, but planning and affect the quality of consolidated forecasts.
when a pharmaceutical company needs a single global view
of product potential, it can also lead to challenges. Without Creating a consistent approach across geographies would be
a common approach, planners at the corporate level may an enormous task, but transparency and alignment were
struggle to reconcile a conflicting patchwork of different models, essential to the company’s health. “We needed to know what our
methodologies and even definitions of basic concepts. revenue and product mix will look like in 2017 and in 2022,”
says the associate director. “If we didn’t control that, the market
Difficulties in building a complete view of the business can would shape those decisions for us.”
ultimately lead business planning astray.

Case Study FORECASTING


THE SOLUTION THE RESULTS
Agreement and alignment on the approach Greater capacity and confidence; less frustration
Using ZS’s decision driven forecasting excellence framework, The company’s partnership with ZS has been transformative:
the company solicited participation from affiliates and regional
leadership to help shape the solution. Overall, the company’s • Greater confidence in forecasts and resulting resource-
forecasting operations were transformed by the changes, allocation decisions for product launches and existing brands
which included: • Threefold efficiency gains with increased forecast volumes for
multiple products, indications and countries
• An integrated global forecasting platform with universal access • Buy-in from nearly 40 local affiliates despite initial skepticism
via an online portal about creating long-term alignment
• Transparency about how forecast outputs drive decision making • Discussion focused on forecast assumptions, business issues
• Clear transition of forecast ownership and improved channels and best practices, rather than technical model conflicts
of communications between global and local teams
• An annual planning kickoff meeting to align global and “I don’t think there are many firms that know the biopharmaceutical
regional marketing and forecasting teams on forecasting market the way ZS does,” says a senior director for the company.
and brand strategy “I’ve worked with external partners before, but not to this degree of
• Ongoing training to support decision driven forecasting interaction and collaboration, and certainly not with a partner who
contributed as much as ZS.”

“I don’t think there are many firms


that know the biopharmaceutical
market the way ZS does.
I’ve worked with external
partners before, but not with
a partner who contributed
as much as ZS.”

ZS Associates is a global leader in sales and marketing consulting, outsourcing, technology and software. For almost 30 years, ZS has
helped companies across a range of industries get the most out of their sales and marketing organizations. From 20 offices around the
world, ZS experts use analytics and deep expertise to help companies make smart decisions quickly and cost effectively. ZS comprises
multiple affiliated legal entities. Learn more at www.zsassociates.com.

Copyright © 2012 ZS Associates. No part of this document may be modified, deleted or expanded by any process or means without prior written permission from ZS Associates.

Anda mungkin juga menyukai